105 related articles for article (PubMed ID: 4975293)
1. Immunization of mice by combinations of inactive fractions of Mycobacterium bovis strain BCG.
Anacker RL; Bickel WD; Brehmer W; Niwa M; Ribi E; Tarmina DF
Proc Soc Exp Biol Med; 1969 Mar; 130(3):723-30. PubMed ID: 4975293
[No Abstract] [Full Text] [Related]
2. [Immunity against Mycobacterium, with special reference to the experiments using BCG cell wall].
Yamamoto K
Kekkaku; 1976 May; 51(5):155-7. PubMed ID: 819704
[No Abstract] [Full Text] [Related]
3. Biologically active components from mycobacterial cell walls. IV. Protection of mice against aerosol infection with virulent mycobacterium tuberculosis.
Ribi E; Meyer TJ; Azuma I; Parker R; Brehmer W
Cell Immunol; 1975 Mar; 16(1):1-10. PubMed ID: 803876
[No Abstract] [Full Text] [Related]
4. Biology of the mycobacterioses. Structure and biological functions of mycobacteria.
Ribi E; Anacker RL; Barclay WR; Brehmer W; Middlebrook G; Milner KC; Tarmina DF
Ann N Y Acad Sci; 1968 Sep; 154(1):41-57. PubMed ID: 4985919
[No Abstract] [Full Text] [Related]
5. Efficacy of mycobacterial cell walls as a vaccine against airborne tuberculosis in the Rheusus monkey.
Ribi E; Anacker RL; Barclay WR; Brehmer W; Harris SC; Leif WR; Simmons J
J Infect Dis; 1971 May; 123(5):527-38. PubMed ID: 5000470
[No Abstract] [Full Text] [Related]
6. Immunization of rabbits with viable BCG and nonliving cell wall vaccines.
Larson CL; Baker RE; Baker MB
Am Rev Respir Dis; 1968 Dec; 98(6):944-53. PubMed ID: 4881317
[No Abstract] [Full Text] [Related]
7. Effects of pretreatment of mice with BCG cell walls in saline on subsequent vaccination with BCG oil droplet vaccine.
Meyer TJ; Anacker RL; Ribi E
Cell Immunol; 1974 Oct; 14(1):52-65. PubMed ID: 4219589
[No Abstract] [Full Text] [Related]
8. Effectiveness of cell walls of Mycobacterium bovis strain BCG administered by various routes and in different adjuvants in protecting mice against airborne infection with Mycobacterium tuberculosis strain H37Rv.
Anacker RL; Barclay WR; Brehmer W; Goode G; List RH; Ribi E; Tarmina DF
Am Rev Respir Dis; 1969 Feb; 99(2):242-8. PubMed ID: 4975012
[No Abstract] [Full Text] [Related]
9. Effects of oil-treated mycobacterial cell walls on the organs of mice.
Barclay WR; Anacker R; Brehmer W; Ribi E
J Bacteriol; 1967 Nov; 94(5):1736-45. PubMed ID: 4965197
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of cell walls from various mycobacteria against airborne tuberculosis in mice.
Brehmer W; Anacker RL; Ribi E
J Bacteriol; 1968 Jun; 95(6):2000-4. PubMed ID: 4970218
[TBL] [Abstract][Full Text] [Related]
11. [The genetic regulation of host response to inoculation with Mycobacterium bovis (BCG) and Mycobacterium tuberculosis H37RV].
Nikonenko BV; Mezhlumova MB; Moroz AM
Biull Eksp Biol Med; 1990 Nov; 110(11):526-8. PubMed ID: 2128037
[TBL] [Abstract][Full Text] [Related]
12. Cell wall skeleton of Mycobacterium bovis BCG enhances the vaccine potential of antigen 85B against tuberculosis by inducing Th1 and Th17 responses.
Back YW; Choi S; Choi HG; Shin KW; Son YJ; Paik TH; Kim HJ
PLoS One; 2019; 14(3):e0213536. PubMed ID: 30849108
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy of cancer: regression of established intradermal tumors after intralesional injection of mycobacterial cell walls attached to oil droplets.
Zbar B; Ribi E; Meyer T; Azuma I; Rapp HJ
J Natl Cancer Inst; 1974 May; 52(5):1571-7. PubMed ID: 4364736
[No Abstract] [Full Text] [Related]
14. Intrapulmonary BCG cell wall vaccination in mice.
Reuman PD; Ayoub EM
Microbios; 1987; 49(198):7-15. PubMed ID: 3550393
[TBL] [Abstract][Full Text] [Related]
15. Plaque-forming cells in the spleens of rabbits immunized with viable BCG bacilli or oil cell wall vaccine from Mycobacterium bovis.
Larson C; Baker MB; Smith D
Am Rev Respir Dis; 1968 Apr; 97(4):715-8. PubMed ID: 4868647
[No Abstract] [Full Text] [Related]
16. Loss of anti-mycobacterial efficacy in mice over time following vaccination with Mycobacterium bovis bacillus Calmette-Guérin.
Ozeki Y; Hirayama Y; Takii T; Yamamoto S; Kobayashi K; Matsumoto S
Vaccine; 2011 Sep; 29(40):6881-7. PubMed ID: 21803102
[TBL] [Abstract][Full Text] [Related]
17. Activation of guinea pig macrophages by cell walls of Mycobacterium bovis, strain BCG.
Kelly MT
Cell Immunol; 1976 Oct; 26(2):254-63. PubMed ID: 824056
[No Abstract] [Full Text] [Related]
18. Differential Mycobacterium bovis BCG vaccine-derived efficacy in C3Heb/FeJ and C3H/HeOuJ mice exposed to a clinical strain of Mycobacterium tuberculosis.
Henao-Tamayo M; Obregón-Henao A; Creissen E; Shanley C; Orme I; Ordway DJ
Clin Vaccine Immunol; 2015 Jan; 22(1):91-8. PubMed ID: 25392011
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting the immunizing activity of ribosomal fractions isolated from Mycobacterium tuberculosis var. bovis strain BCG.
Portelance V; Brasseur R; Boulanger RP
Can J Microbiol; 1975 Oct; 21(10):1492-9. PubMed ID: 1104114
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy of guinea pig cancer with BCG.
Zbar B
Johns Hopkins Med J Suppl; 1974; 3():121-30. PubMed ID: 4608693
[No Abstract] [Full Text] [Related]
[Next] [New Search]
